|
Status |
Public on Dec 16, 2016 |
Title |
Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition |
Organisms |
Homo sapiens; Mus musculus; Rattus norvegicus |
Experiment type |
Expression profiling by array Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
27960085, 28256512 |
|
Submission date |
Dec 24, 2014 |
Last update date |
Jul 10, 2019 |
Contact name |
Yujin Hoshida |
Organization name |
University of Texas Southwestern Medical Center
|
Street address |
5323 Harry Hines Blvd
|
City |
Dallas |
State/province |
TX |
ZIP/Postal code |
75390 |
Country |
USA |
|
|
Platforms (4)
|
GPL6101 |
Illumina ratRef-12 v1.0 expression beadchip |
GPL6885 |
Illumina MouseRef-8 v2.0 expression beadchip |
GPL14844 |
Illumina HiSeq 2000 (Rattus norvegicus) |
GPL19589 |
NanoString Prognostic Liver Signature panel (PLS) - Slim (32 genes) |
|
Samples (298)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE63726 |
Gene expression profiles of fractionated cells from cirrhotic rat livers |
GSE70297 |
Expression profiles of prognostic 32-gene liver signature in surgically resected Japanese hepatocellular carcinoma patients |
GSE71379 |
Gene expression profile of liver tissue from carbon tetrachloride (CCl4)-treated mouse cultured ex vivo |
GSE72960 |
Transcriptome profiles of cirrhotic liver treated with lysophosphatidic acid pathway inhibitors |
|
Relations |
BioProject |
PRJNA271169 |